EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to cut chemo time and side effects for breast cancer patients
Disease control Recruiting nowThis large, phase 3 trial is comparing two chemotherapy approaches for early-stage triple-negative breast cancer. It aims to see if a shorter treatment that avoids a harsh drug called an anthracycline works as well as the standard, longer regimen. The study will enroll 2,400 part…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo aims to wipe out tough breast cancer before surgery
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called ivonescimab to standard chemotherapy before surgery is safe and more effective for people with early-stage triple-negative breast cancer (TNBC). About 34 participants will receive the drug combination for about …
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Doctors test custom cancer vaccine to train immune system
Disease control Recruiting nowThis early-stage trial is testing a new, personalized vaccine for triple-negative breast cancer (TNBC). The vaccine is custom-made from a piece of a patient's own tumor and is designed to teach their immune system to recognize and attack the cancer. Researchers are studying the v…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Could skipping extra treatment keep cancer away just as well?
Disease control Recruiting nowThis large study is for people with early-stage triple-negative breast cancer who had no detectable cancer left after their initial chemo-immunotherapy and surgery. It aims to find out if simply watching closely (observation) works just as well at preventing the cancer from comin…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Mayo clinic tests 'Crystal Ball' for cancer treatment success
Knowledge-focused Recruiting nowThis study aims to collect tumor tissue samples from patients with various cancers to test a new diagnostic platform called Elephas. The goal is to see how accurately this tool can predict whether patients will respond to immunotherapy treatments before they begin. Researchers wi…
Matched conditions: EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC